No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
We Think ORIC Pharmaceuticals (NASDAQ:ORIC) Needs To Drive Business Growth Carefully
ORIC Pharmaceuticals To Present ORIC-944 Preclinical At AACR 2025 On Apr. 27
ORIC Pharmaceuticals Announces ORIC-944 Preclinical Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting
Top Premarket Decliners
Oric Pharmaceuticals Expands Equity Incentive Plan for Growth